Ladenburg raised the firm’s price target on Artivion to $29.60 from $27.35 and keeps a Buy rating on the shares following the Q2 report.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AORT:
- Artivion Reports Second Quarter 2024 Financial Results
- Artivion Inc. (AORT) Q2 Earnings Cheat Sheet
- Lake Street highlights five ‘bargain bin’ small cap healthcare ideas for 2H
- Artivion price target raised to $30 from $28 at Lake Street
- Artivion Bolsters Endospan Partnership with Enhanced Financing Terms